MG
Therapeutic Areas
Immunovant Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Batoclimab | IgG-mediated autoimmune diseases | Phase 2b/3 |
| IMVT-1402 | IgG-mediated autoimmune diseases | Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| Batoclimab | IgG-mediated autoimmune diseases | Phase 2b/3 |
| IMVT-1402 | IgG-mediated autoimmune diseases | Phase 1 |